Latest stories on VTRS
Why Did XOM, BTE, VTRS Jump To 52-Week Highs Today?
Stocktwits News74 · bullishgeneral
Viatris Inc. stock rises Tuesday, outperforms market
MarketWatch58 · neutralgeneral
Earnings Preview: What to Expect From Viatris' Report
Barchart50 · neutralearnings
Viatris price target raised to $14 from $13 at Piper Sandler
The Fly63 · neutralanalyst
Viatris Inc. stock falls Friday, underperforms market
MarketWatch42 · neutralgeneral
Viatris Inc. stock falls Wednesday, underperforms market
MarketWatch42 · neutralgeneral
Viatris price target raised to $20 from $18 at JPMorgan
The Fly63 · neutralanalyst
Viatris Inc. stock rises Tuesday, outperforms market
MarketWatch58 · neutralgeneral
Viatris Inc. stock rises Friday, outperforms market
MarketWatch58 · neutralgeneral
Viatris announces FDA approval of ryzumvi for treatment of presbyopia in adults
The Fly74 · bullishproduct/pr
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
StockTitan78 · bullishproduct/pr
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
PR Newswire78 · bullishproduct/pr
Opus Genetics Secures FDA Approval For Eye Drops – Set To Receive Milestone Payment
Stocktwits News74 · bullishproduct/pr
Viatris, Opus granted FDA label expansion for Ryzumvi in presbyopia
Seeking Alpha74 · bullishproduct/pr
Viatris Inc. stock rises Thursday, outperforms market
MarketWatch58 · neutralgeneral
Viatris Inc. stock rises Wednesday, outperforms market
MarketWatch58 · neutralgeneral
Viatris Inc. stock falls Tuesday, underperforms market
MarketWatch42 · neutralgeneral
SA analyst upgrades/downgrades: META, VTRS, MRVL, COKE
Seeking Alpha50 · neutralanalyst
Viatris: Is The Pacira Deal A Game Changer? (Rating Upgrade)
Seeking Alpha67 · bullishanalyst
Viatris: Improved Confidence Drives M&A Action Again
Seeking Alpha58 · neutralanalyst
Stocktwits M&A Watch: Viatris-Pacira Deal, Coca-Cola’s Costa Coffee Sale, Devon’s Eagle Ford Divestiture In Focus
Stocktwits News58 · neutralm&a
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
Seeking Alpha55 · neutralgeneral
Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights
Stocktwits News58 · neutralm&a
Viatris Inc. stock rises Friday, outperforms market
MarketWatch58 · neutralgeneral
Viatris To Acquire Pacira BioSciences: What Investors Should Know
Seeking Alpha63 · neutralm&a